Literature DB >> 25500142

Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease.

Wenjin Xu1, Shane Fitzgerald2, Ralph A Nixon3, Efrat Levy4, Donald A Wilson5.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder which is the most common cause of dementia in the elderly today. One of the earliest symptoms of AD is olfactory dysfunction. The present study investigated the effects of amyloid β precursor protein (AβPP) metabolites, including amyloid-β (Aβ) and AβPP C-terminal fragments (CTF), on olfactory processing in the lateral entorhinal cortex (LEC) using the Tg2576 mouse model of human AβPP over-expression. The entorhinal cortex is an early target of AD related neuropathology, and the LEC plays an important role in fine odor discrimination and memory. Cohorts of transgenic and age-matched wild-type (WT) mice at 3, 6, and 16months of age (MO) were anesthetized and acute, single-unit electrophysiology was performed in the LEC. Results showed that Tg2576 exhibited early LEC hyperactivity at 3 and 6MO compared to WT mice in both local field potential and single-unit spontaneous activity. However, LEC single-unit odor responses and odor receptive fields showed no detectable difference compared to WT at any age. Finally, the very early emergence of olfactory system hyper-excitability corresponded not to detectable Aβ deposition in the olfactory system, but rather to high levels of intracellular AβPP-CTF and soluble Aβ in the anterior piriform cortex (aPCX), a major afferent input to the LEC, by 3MO. The present results add to the growing evidence of AβPP-related hyper-excitability, and further implicate both soluble Aβ and non-Aβ AβPP metabolites in its early emergence.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid-β; AβPP C-terminal fragments; AβPP metabolites; Lateral entorhinal cortex; Olfaction; Single-unit

Mesh:

Substances:

Year:  2014        PMID: 25500142      PMCID: PMC4324092          DOI: 10.1016/j.expneurol.2014.12.008

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  76 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

Review 2.  Loss of olfactory function in dementing disease.

Authors:  C Murphy
Journal:  Physiol Behav       Date:  1999-04

Review 3.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

4.  Lateral entorhinal modulation of piriform cortical activity and fine odor discrimination.

Authors:  Julie Chapuis; Yaniv Cohen; Xiaobin He; Zhijan Zhang; Sen Jin; Fuqiang Xu; Donald A Wilson
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

5.  Prevalence of olfactory impairment in older adults.

Authors:  Claire Murphy; Carla R Schubert; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; David M Nondahl
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

6.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 7.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

Review 8.  The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes.

Authors:  Hoang S Nhan; Karen Chiang; Edward H Koo
Journal:  Acta Neuropathol       Date:  2014-10-07       Impact factor: 17.088

9.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

10.  In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice.

Authors:  Jose Morales-Corraliza; Matthew J Mazzella; Jason D Berger; Nicole S Diaz; Jennifer H K Choi; Efrat Levy; Yasuji Matsuoka; Emmanuel Planel; Paul M Mathews
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more
  26 in total

1.  Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Wenxiu Yang; Yan Zou; Man Zhang; Nan Zhao; Qi Tian; Min Gu; Wei Liu; Rui Shi; Yang Lü; Weihua Yu
Journal:  Neurochem Res       Date:  2015-06-05       Impact factor: 3.996

Review 2.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

Review 3.  Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.

Authors:  Ralph A Nixon
Journal:  FASEB J       Date:  2017-07       Impact factor: 5.191

4.  Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments.

Authors:  Katherine Y Peng; Paul M Mathews; Efrat Levy; Donald A Wilson
Journal:  Neuroscience       Date:  2016-12-18       Impact factor: 3.590

Review 5.  What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?

Authors:  Benedikt Zott; Marc Aurel Busche; Reisa A Sperling; Arthur Konnerth
Journal:  Annu Rev Neurosci       Date:  2018-07-08       Impact factor: 12.449

6.  Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.

Authors:  Brett S East; Gloria Fleming; Kathy Peng; Jonas K Olofsson; Efrat Levy; Paul M Mathews; Donald A Wilson
Journal:  Neuroscience       Date:  2018-04-18       Impact factor: 3.590

Review 7.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

8.  Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease.

Authors:  Tatiana Melnikova; DaMin Park; Lauren Becker; Deidre Lee; Eugenia Cho; Nuzhat Sayyida; Jing Tian; Karen Bandeen-Roche; David R Borchelt; Alena V Savonenko
Journal:  Neurobiol Dis       Date:  2016-08-26       Impact factor: 5.996

9.  Alterations in odor hedonics in the 5XFAD Alzheimer's disease mouse model and the influence of sex.

Authors:  Elizabeth R Roberts; Amanda M Dossat; María Del Mar Cortijo; Patrik Brundin; Daniel W Wesson
Journal:  Behav Neurosci       Date:  2020-08-06       Impact factor: 1.912

10.  Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of Alzheimer's disease neuropathology and atypical effects of the cholinergic antagonist atropine.

Authors:  David Alcantara-Gonzalez; Elissavet Chartampila; Chiara Criscuolo; Helen E Scharfman
Journal:  Neurobiol Dis       Date:  2021-01-20       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.